Specialty Pharma Journal Specialty, Precision & Technology

CAMBRIDGE, Mass., March 22, 2017 – Akashi Therapeutics, Inc. a clinical stage biopharmaceutical company developing …

The development of new treatments for pancreatic cancer is set to be transformed by a …

REDWOOD CITY, Calif., March 24, 2017 /PRNewswire/ — Genomic Health, Inc. (Nasdaq: GHDX) today announced …

TARRYTOWN, N.Y., March 22, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a …

Researchers with the National Human Genome Research Institute (NHGRI), part of the National Institutes of …

Tel Aviv, Israel – March 23, 2017 – BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the …

Median reduction in hereditary angioedema (HAE) attack rate relative to placebo was 95% at the …

Columbus, Ohio – A large, new study of adults with acute myeloid leukemia (AML) correlates …

Lexington, Mass. – March 22, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced …

ST. PAUL, Minn.–(BUSINESS WIRE)–Two new studies find commercially insured members with diabetes had 2.5 times …

CASTRES and PARIS, France March 21, 2017 – Pierre Fabre, the second largest privately held …

Milan, Italy and Morristown, NJ, U.S.A., – March 21, 2017 – Newron Pharmaceuticals S.p.A. (“Newron”, …

HERTFORDSHIRE, England and PITTSBURGH, March 20, 2017 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL), a …